N-Acetylimidazolidinone → HCID 71252694, compound

HRID 2412014Notes

Reaction equation

HRID 2412014 reaction equation
Cl[C:2]1[N:7]=[N:6][C:5]([C:8]([N:10]2[CH2:15][CH2:14][N:13]([C:16]3[C:21]([CH3:22])=[CH:20][C:19]([CH3:23])=[CH:18][N:17]=3)[CH2:12][CH2:11]2)=[O:9])=[CH:4][CH:3]=1.C([N:27]1[CH2:31][CH2:30][NH:29][C:28]1=[O:32])(=O)C>>[CH3:22][C:21]1[C:16]([N:13]2[CH2:14][CH2:15][N:10]([C:8]([C:5]3[N:6]=[N:7][C:2]([N:27]4[CH2:31][CH2:30][NH:29][C:28]4=[O:32])=[CH:3][CH:4]=3)=[O:9])[CH2:11][CH2:12]2)=[N:17][CH:18]=[C:19]([CH3:23])[CH:20]=1

Participants

3

Reactant 2

HCID 79350N-AcetylimidazolidinoneHCID 86676766HCID 86676766, compound

Product 1

HCID 71252694HCID 71252694, compoundYield 12.2%

Procedure

Using (6-chloropyridazin-3-yl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone (150 mg) described in Preparation Example 230 and 1-acetylimidazolidin-2-one (87 mg) and by the reaction and treatment in the same manner as in Example 638, the title compound (21 mg) was obtained.

Sources & evidence

ORD record
ord-4ccb71fffa4c4a6f85f2e12e2e161ccb
Source dataset
uspto-grants-2014_08
Patent number
US08816079B2

Reaction notes

Loading…